期刊文献+

细胞学结合人乳头瘤病毒DNA检测在宫颈病变诊断中的意义 被引量:1

The significance of LPT combined with HPV-DNA detection in the screening of cervical pathology changes
下载PDF
导出
摘要 目的探讨液基细胞学(LPT)联合人乳头瘤病毒(HPV)-DNA检测诊断宫颈病变的临床意义。方法对我院妇产科门诊2010年1月至9月就诊的444例妇女实施宫颈LPT及HPV-DNA检测。对不典型鳞状上皮细胞(ASCUS)以上者和(或)HPV-DNA阳性者进行宫颈组织活检,活检结果高于轻度宫颈上皮内瘤变(CINⅠ)的为阳性。结果 444名LPT检查者,ASCUS以上者50例,HPV-DNA阳性194例,其阳性检出率分别为11.3%、43.7%,LPT及HPV-DNA均为阳性者31例,检出率为72.8%,其中CINⅠ~Ⅲ23例,宫颈癌5例,诊断符合率为93%。病理结果示:CINⅠ18例,CINⅡ32例,CINⅢ34例,宫颈癌12例,HPV感染率分别为44%(8/18)、28%(9/32)、56%(19/34)、75%(9/12)。结论癌前病变与HPV感染密切相关,LPT结合HPV-DNA检测可提高宫颈病变诊断率。 Objective To investigate the significance of LPT combined with HPV-DNA detection in the screening of cervical pathology changes.Methods To take LPT combined with HPV-DNA detection for the 444 clinical visitors of our hospital during January to September in 2010,and cervix histology biopsy was performed for those whose result is above ASCUS or HPV-DNA(+).The positive rate are higher than cervical intraepithelial neoplasia(CINⅠ).Results In the 444 cases who took LPT,50 were above ASCUS,194 were HPV-DNA(+),the positive rate are 11.3% and 43.7% respectively.Both LPT(+) and HPV-DNA(+) have 31(72.8%)cases,among which CINⅠ~Ⅲ 23,cervical cancer 5.The coincidence rate is 93%.The pathology consequence shows: 44%(8/18),28%(9/32),56%(19/34) and 75%(9/12),respectively.Conclusion Cervical lesion is closely related with HPV.LPT combined with HPV-DNA detection can increase the prediction rate of cervical lesion.
机构地区 山西省人民医院
出处 《山西医药杂志(上半月)》 CAS 2011年第10期970-971,共2页 Shanxi Medical Journal
关键词 细胞学技术 DNA探针 HPV 宫颈疾病 Cytological technique DNA probes HPV Cervix diseases
  • 相关文献

参考文献5

二级参考文献29

  • 1赖炜玲,屈秦红,籍生萍,牛新强.TCT在妇产科临床的应用[J].临床医药实践,2004,13(12):917-918. 被引量:9
  • 2郎景和.子宫颈病变防治的几个问题[J].世界医学杂志,2004,8(11):1-3. 被引量:84
  • 3何淑英,杨丽君,龙燕芬.宫颈上皮内瘤变早期诊断的临床观察[J].中国妇幼保健,2006,21(19):2729-2731. 被引量:7
  • 4李亚里,杨怡卓.人乳头瘤病毒亚型检测在宫颈病变分流管理中的意义[J].中国实用妇科与产科杂志,2007,23(7):501-503. 被引量:55
  • 5Bekkers RL, Massuger LF, Buhen Jet al. Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer [J]. Rev Med Virol, 2004, 14 (2) : 95.
  • 6Dell G, Gaston K. Human papillomaviruses and their role in cervical cancer[J].Cell Mol Life Sci, 2001, 58 (12 -13) : 1923.
  • 7Mark Spitzer. Cervical screening adjuncts: recent advances[J]. Am J Obstet Gynecol, 1998, 179 (2): 544.
  • 8Wang KL, Wang TY, Huang YC et al. Human papillomavirus type and clinical manifestation in seven cases of large - cell neuroendocrine cervical carcinoma [J]. J Formos Med Assoc, 2009, 108 (5) : 428.
  • 9Lorincz AT, Richart RM. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs[J]. Arch Pathol Lab Med, 2003, 127 (8): 959.
  • 10Wright TV, Denny L, Kuhn Let al. HPV DNA testing of self - collected vaginal samples compared with cytologic screening to detect cervical cancer[J].JAMA, 2000, 283 (1): 81.

共引文献73

同被引文献8

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部